Today: 23 January 2026
Subscribe
Browse Category

NASDAQ:GTLB News 23 January 2026

GitLab stock whipsaws: GTLB holds gains in premarket after 13% surge

GitLab stock whipsaws: GTLB holds gains in premarket after 13% surge

New York, Jan 23, 2026, 05:04 ET — Premarket GitLab Inc shares (GTLB.O) ticked up slightly in premarket trading on Friday, building on a strong bounce that pushed the DevSecOps software company over 12% higher the day before. The stock hovered near $37.60, up roughly 0.5%. (Google) The move is significant since GitLab has hovered near its lows, and Thursday’s…
23 January 2026
····

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop